When one cloud outage can hit thousands of companies, building redundancy to withstand single-provider failures is now ...
Continues to drive enrollment with increase to 78% now consentedBlinded response activity tracking within expected range ...
Live video webcast with Walter Klemp, Chairman and Chief Executive Officer, on Tuesday, December 2nd at 4:00 PM ET ...
Arabian International Healthcare Holding Co.’s (Tibbiyah) signed, on Nov. 20, a conditional share purchase agreement (SPA) to acquire 49% of NephroCare Health Services Saudi Arabia Co. This will ...
Mohali: In a major step toward strengthening digital education, the Punjab School Education Board (PSEB) has announced key reforms in the teaching and evaluation system of Computer Science for Classes ...
LOUISVILLE, Ky., Nov. 14, 2025 /PRNewswire/ -- Cognision, provider of advanced neurobiomarker technology, announces its partnership with Kynexis to utilize the COGNISION® System in Kynexis' Phase 2 ...
Oct 14 (Reuters) - U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical (4502.T), opens new tab, deepening their ...
Across the globe, few nations have faced as many natural disasters as Japan — from typhoons and tsunamis to earthquakes and volcanic eruptions. Yet, out of this constant exposure to risk has emerged ...
This is read by an automated voice. Please report any issues or inconsistencies here. The Trump administration launched an investigation into alleged antisemitism in the California State University ...
Continues to drive enrollment with increase to 78% now consentedBlinded response activity tracking within expected range Consented subjects now across seven countries supporting the expansion of the ...
Section 1. Purpose and Policy. America has long led the world in innovation, technological advancement, and design. But with a sprawling ecosystem of digital services offered to Americans, the ...
- Continues recruitment and opens US and EU sites for the Phase 2B/3 MIRACLE trial - 20+ additional clinical sites in Europe and the US expected to begin recruitment by the end of Q3 - Anticipated ...